Saffron study for dry eye pulled before it began
NCT ID NCT06240364
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a saffron-based supplement called AffronEye® could improve dry eye symptoms in university staff and students. It planned to compare the supplement to a placebo over 84 days using eye tests and symptom questionnaires. However, the study was withdrawn before enrolling anyone, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alicante
San Vicent del Raspeig, Alicante, 03690, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Supplement shows promise for dry eye sufferers in new study
- Scientists hunt for eye disease clues in your tears
- New eye drop shows promise for dry eye sufferers
- New eye drops aim to soothe dry eye sufferers
- New gel aims to soothe dry eyes in glaucoma patients
- New eye drop T2769 takes on Hylo-Forte in dry eye showdown